Abstracts deadline Friday 24 April 2026! Submit now

d
h
m
s

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s
Days
Hrs
Mins

Dr Emily Littlejohn

Dr. Littlejohn is the Director of the Lupus Clinic at Cleveland Clinic and acts the Principal Investigator for multiple cellular therapy clinical trials in systemic lupus erythematosus including CAR-T trials. She is also the PI of the SLE biobank and is a Clinical Associate Professor of Medicine at Cleveland Clinic Learner College of Medicine of Case Western Reserve University.

Dr. Littlejohn is the Director of the Lupus Clinic at Cleveland Clinic and acts the Principal Investigator for multiple cellular therapy clinical trials in systemic lupus erythematosus including CAR-T trials. She is also the PI of the SLE biobank and is a Clinical Associate Professor of Medicine at Cleveland Clinic Learner College of Medicine of Case Western Reserve University.

Sessions

Presentations

Share

Key dates

Registrations
Abstracts

More speakers

Dr. Anindita Santosa
Aaria Rheumatology, Singapore
Prof. Xenofon Baraliakos
Rheumazentrum Ruhrgebiet, Europe
Dr. Kenneth Saag
University Of Alabama At Birmingham, United States
Prof. Denis Poddubnyy
University of Toronto, Canada
Prof Gulen Hatemi
Istanbul University - Cerrahpasa. Turkiye
Prof Lai-Shan Tam
Faculty Of Medicine, The Chinese University Of Hong Kong, China
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Tuesday 23 June, 2026

The countdown is on

Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.